Paul Auerbach, MDWilderness Medicine
Advertisement

New Recommendations for Tetanus Prophylaxis in Wound Management

Paul Auerbach, M.D.

In medical parlance, “prophylaxis” refers to the process (usually by vaccination [immunization] or administration of a protective drug [such as is done to prevent an infection, such as malaria]) whereby an adverse medical condition, such as an infection or blood clot formation, is prevented. So,”tetanus prophylaxis” refers to the situation where a person is given an injection or series of injections to prevent infection with the bacterium Clostridium tetani, the causative agent of a tetanus infection. Because infection with tetanus can be very serious and even life-threatening, it is important for each of us to have active immunity.

The Immunization Branch or the State of California Department of Health Services recently released a new recommendation for tetanus prophylaxis in wound management. This was necessary because of the increasing prevalence of pertussis (“whooping cough”) in our communities, which necessitates that greater attention be paid to preventing this disease, which is caused by the bacterium Bordetella pertussis.

From this point forward, it is recommended that adolescents and adults who require tetanus toxoid vaccine for wound management should receive a single dose of Tdap (tetanus, reduced diphtheria, and acellular pertussis) vaccine instead of Td (tetanus, diptheria) vaccine.

Healthcare workers who have direct patient contact are also recommended by the Centers for Disease Control (CDC) to get a dose of Tdap vaccine to protect themselves, their families, and their patients.

Health care providers need to be aware of which vaccines are licensed for which age groups:

1. Tdap (tetanus, diphtheria, pertussis): ADACEL® (sanofi pasteur) ages 11-64 years; Boostrix® (GlaxoSmithKline) ages 10-18 years
2. DTaP (diphtheria, tetanus, pertussis): DAPTACEL® (sanofi pasteur) ages 6 weeks to 7 years; TRIPEDIA® (sanofi pasteur) ages 6 weeks to 7 years; Infanrix® (GlaxoSmithKline) ages 6 weeks to 7 years; Pediarix® (GlaxoSmithKline) ages 6 weeks to 7 years
3. Td (tetanus, diphtheria): Td (sanofi pasteur) ages 7 years and older

One obvious question is which vaccine should be used for children between the ages of 7 years and 10 years? It is probably best to use the DTaP vaccine for this age group, even though no vaccine is licensed for this age group, and either Tdap or DTaP would likely induce the proper immunities.

Tags: , , , , , , , ,

Labels: , ,

Permalink | Email Post

1 Comments:

  • At Sat Jul 28, 11:34:00 PM 2007, Blogger Nancy said…

    i became severly disabled from 2 of 3 hep be vaccines and i have been told over and over never to get any more vaccines. I am not sure if it was the thimeresol preservative or something else in the vaccine that caused it, but it has been 20 years since my last tetanus vaccine, and i now live in the country and i gashed my finger today down several layers of skin, on a rock that had wet soil on it. what am i supposed to do since i cannot take any vaccines?

     

Post a Comment

<< Home

The Healthline Site, its content, such as text, graphics, images, search results, HealthMaps, Trust Marks, and other material contained on the Healthline Site ("Content"), its services, and any information or material posted on the Healthline Site by third parties are provided for informational purposes only. None of the foregoing is a substitute for professional medical advice, examination, diagnosis, or treatment. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Healthline Site. If you think you may have a medical emergency, call your doctor or 911 immediately. Please read the Terms of Service for more information regarding use of the Healthline Site.